ADD CONDITION

items per page

Dermaquest Skin Therapy Post-Skin Resurfacing Balm

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Hydrocortisone 10 mg/1 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2010
Label revision date
August 19, 2010
Active ingredient
Hydrocortisone 10 mg/1 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2010
Label revision date
August 19, 2010
Manufacturer
Allure Labs, Inc.
Registration number
part348
NDC root
62742-4051

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Post-Skin Resurfacing Balm is a soothing product designed to promote the healing of itchy skin while keeping it hydrated. This balm is particularly beneficial after skin resurfacing procedures, helping to restore comfort and moisture to your skin. It is distributed by DermaQuest, Inc., based in Hayward, California.

Uses

This medication is designed to help promote the healing of itchy skin, providing relief and comfort. It works by keeping your skin hydrated, which is essential for maintaining its health and preventing dryness that can lead to irritation.

You can feel confident using this product, as there are no known teratogenic effects (which means it does not cause birth defects) associated with it. This makes it a safe option for those concerned about potential risks.

Dosage and Administration

To use this medication effectively, you should apply it directly to your skin as directed by your skincare professional. This application helps keep your skin hydrated and supports the healing process. Make sure to follow their instructions closely for the best results.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

When using this medication, it's important to remember that it is for external use only. If you experience any bleeding or if your condition worsens, you should consult a doctor immediately.

Please be aware of these warnings to ensure your safety while using the product.

Warnings and Precautions

This product is for external use only, so please avoid ingesting it. If you accidentally swallow it, seek medical help immediately or contact a Poison Control Center. It's also important to keep this product out of reach of children to ensure their safety.

If you notice any bleeding or if your condition worsens while using this product, stop using it and call your doctor for further advice. Always prioritize your health and safety by consulting a healthcare professional if you have any concerns.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have any concerns about your health.

Pregnancy Use

There is currently no specific information available about the use of DermaQuest Skin Therapy Post-Skin Resurfacing Balm (hydrocortisone cream) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the drug insert.

If you are pregnant or planning to become pregnant, it is important to consult with your healthcare provider before using this product to ensure it is safe for you and your baby. Always prioritize open communication with your doctor regarding any medications or treatments you are considering during this time.

Lactation Use

Currently, there is no specific information available about the use of DermaQuest Skin Therapy Post-Skin Resurfacing Balm for nursing mothers or its effects during lactation (the period of breastfeeding). This means that if you are breastfeeding, it’s important to consult with your healthcare provider before using this product to ensure it is safe for you and your baby. Always prioritize your health and your infant's well-being when considering new skincare products.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child accidentally swallows it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

While there is no specific information about how this medication should be used by older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and may be taking multiple medications, it’s always a good idea to discuss any concerns with your healthcare provider. They can help determine the best approach for you, considering any potential risks or interactions with other treatments you may be using.

If you or a loved one is an older adult, make sure to keep your healthcare team informed about all medications and health conditions to ensure safe and effective care.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's great to know that there are no reported interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product, as it should not be reused. Following these guidelines will help maintain the integrity of the product and ensure your safety.

Additional Information

No further information is available.

FAQ

What is Post-Skin Resurfacing Balm used for?

Post-Skin Resurfacing Balm promotes healing of itchy skin and keeps the skin hydrated.

Who distributes Post-Skin Resurfacing Balm?

It is distributed by DermaQuest, Inc., located in Hayward, CA.

Are there any teratogenic effects associated with this balm?

No teratogenic effects are mentioned for Post-Skin Resurfacing Balm.

What should I do if I experience bleeding while using this balm?

You should ask a doctor if bleeding occurs or if your condition worsens.

Is there any specific information regarding use during pregnancy?

No specific information regarding pregnancy use or safety concerns is provided.

How should I store Post-Skin Resurfacing Balm?

Store it at room temperature, protect it from light, and keep the container tightly closed.

What should I do if I accidentally swallow the balm?

If swallowed, get medical help or contact a Poison Control Center right away.

Is Post-Skin Resurfacing Balm safe for children?

Keep it out of reach of children, as it is for external use only.

Packaging Info

Below are the non-prescription pack sizes of Dermaquest Skin Therapy Post-Skin Resurfacing Balm (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dermaquest Skin Therapy Post-Skin Resurfacing Balm.
Details

Drug Information (PDF)

This file contains official product information for Dermaquest Skin Therapy Post-Skin Resurfacing Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Post-Skin Resurfacing Balm is distributed by DermaQuest, Inc., located in Hayward, California. The product is designed to provide post-procedural support for skin recovery following resurfacing treatments. For further information, the company’s website is available at dermaquestinc.com.

Uses and Indications

This drug is indicated for the promotion of healing in patients with itchy skin. It is also intended to maintain skin hydration.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product should be applied to the skin as directed by the skincare professional. This application is intended to maintain skin hydration and promote healing. It is essential to follow the specific instructions provided by the healthcare provider to ensure optimal results.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to seek medical attention if bleeding occurs or if the condition worsens.

It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse. In the event of ingestion, patients should be instructed to seek emergency medical help or contact a Poison Control Center immediately.

Patients should be advised to discontinue use and consult their healthcare provider if any bleeding occurs or if their condition deteriorates. Regular monitoring of the patient's condition is recommended to ensure safety and efficacy during treatment.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of bleeding or if conditions worsen, it is advised to consult a healthcare professional.

While specific adverse reactions have not been detailed in the provided data, the warnings highlight the importance of monitoring for any serious reactions, particularly those related to bleeding. It is essential for patients to remain vigilant and seek medical advice if they experience any concerning symptoms during use.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dermaquest Skin Therapy Post-Skin Resurfacing Balm (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dermaquest Skin Therapy Post-Skin Resurfacing Balm.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of DermaQuest Skin Therapy Post-Skin Resurfacing Balm (hydrocortisone cream) in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to exercise caution and consult relevant clinical guidelines when treating pregnant patients with this product.

Lactation

There is no specific information regarding the use of DermaQuest Skin Therapy Post-Skin Resurfacing Balm in lactating mothers or any lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers. There are no known data on excretion in breast milk or effects on breastfed infants associated with this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of the situation and the need for prompt action if ingestion occurs.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Dermaquest Skin Therapy Post-Skin Resurfacing Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Dermaquest Skin Therapy Post-Skin Resurfacing Balm, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.